Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Income from Non-Controlling Interests (2017 - 2025)

BioCorRx (BICX) has disclosed Income from Non-Controlling Interests for 7 consecutive years, with $886539.0 as the latest value for Q4 2025.

  • Quarterly Income from Non-Controlling Interests rose 695.24% to $886539.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 218.17% year-over-year, with the annual reading at -$68617.0 for FY2025, 35.25% up from the prior year.
  • Income from Non-Controlling Interests hit $886539.0 in Q4 2025 for BioCorRx, down from $1.1 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $1.1 million in Q3 2025 to a low of -$1.6 million in Q1 2021.
  • Historically, Income from Non-Controlling Interests has averaged -$360205.3 across 3 years, with a median of -$146398.0 in 2024.
  • Biggest YoY gain for Income from Non-Controlling Interests was 4090.03% in 2025; the steepest drop was 764.01% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at -$1.3 million in 2021, then skyrocketed by 88.28% to -$148938.0 in 2024, then surged by 695.24% to $886539.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for BICX at $886539.0 in Q4 2025, $1.1 million in Q3 2025, and -$143858.0 in Q2 2025.